↓ Skip to main content

PLOS

A Glucose BioFuel Cell Implanted in Rats

Overview of attention for article published in PLOS ONE, May 2010
Altmetric Badge

Mentioned by

news
4 news outlets
blogs
2 blogs
twitter
8 X users
patent
5 patents
facebook
1 Facebook page

Readers on

mendeley
307 Mendeley
citeulike
2 CiteULike
Title
A Glucose BioFuel Cell Implanted in Rats
Published in
PLOS ONE, May 2010
DOI 10.1371/journal.pone.0010476
Pubmed ID
Authors

Philippe Cinquin, Chantal Gondran, Fabien Giroud, Simon Mazabrard, Aymeric Pellissier, François Boucher, Jean-Pierre Alcaraz, Karine Gorgy, François Lenouvel, Stéphane Mathé, Paolo Porcu, Serge Cosnier

Abstract

Powering future generations of implanted medical devices will require cumbersome transcutaneous energy transfer or harvesting energy from the human body. No functional solution that harvests power from the body is currently available, despite attempts to use the Seebeck thermoelectric effect, vibrations or body movements. Glucose fuel cells appear more promising, since they produce electrical energy from glucose and dioxygen, two substrates present in physiological fluids. The most powerful ones, Glucose BioFuel Cells (GBFCs), are based on enzymes electrically wired by redox mediators. However, GBFCs cannot be implanted in animals, mainly because the enzymes they rely on either require low pH or are inhibited by chloride or urate anions, present in the Extra Cellular Fluid (ECF). Here we present the first functional implantable GBFC, working in the retroperitoneal space of freely moving rats. The breakthrough relies on the design of a new family of GBFCs, characterized by an innovative and simple mechanical confinement of various enzymes and redox mediators: enzymes are no longer covalently bound to the surface of the electron collectors, which enables use of a wide variety of enzymes and redox mediators, augments the quantity of active enzymes, and simplifies GBFC construction. Our most efficient GBFC was based on composite graphite discs containing glucose oxidase and ubiquinone at the anode, polyphenol oxidase (PPO) and quinone at the cathode. PPO reduces dioxygen into water, at pH 7 and in the presence of chloride ions and urates at physiological concentrations. This GBFC, with electrodes of 0.133 mL, produced a peak specific power of 24.4 microW mL(-1), which is better than pacemakers' requirements and paves the way for the development of a new generation of implantable artificial organs, covering a wide range of medical applications.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 307 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 5 2%
France 3 <1%
Japan 3 <1%
United Kingdom 2 <1%
Germany 2 <1%
Switzerland 1 <1%
Poland 1 <1%
Unknown 290 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 72 23%
Researcher 45 15%
Student > Master 45 15%
Professor > Associate Professor 25 8%
Student > Bachelor 24 8%
Other 41 13%
Unknown 55 18%
Readers by discipline Count As %
Engineering 66 21%
Chemistry 59 19%
Agricultural and Biological Sciences 42 14%
Biochemistry, Genetics and Molecular Biology 15 5%
Chemical Engineering 14 5%
Other 44 14%
Unknown 67 22%